Tech Company Financing Transactions
Syndexa Pharmaceuticals Funding Round
Syndexa Pharmaceuticals closed a Series B funding round on 1/6/2012. Investors included MP Healthcare Venture Management.
Transaction Overview
Company Name
Announced On
1/6/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
MP Healthcare Venture Management (Tetsuro Iwata)
Proceeds Purpose
The proceeds from our Series B1 will enable us to progress the preclinical development of our Endoplasmic Reticulum (ER) modulating compounds towards development candidate selection, and will allow us to validate the therapeutic potential of our most promising compounds in various indications of ER dysfunction.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
480 Arsenal Street Building 1
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Overview
The company develops drugs targeting novel biological mechanisms for the treatment and prevention of metabolic diseases including obesity, type 2 diabetes and cardiovascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Teo Uysal
Browse more venture capital transactions:
Prev: 1/6/2012: NumberFire venture capital transaction
Next: 1/6/2012: Chartbeat venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs